Derivation of a novel SARS–coronavirus replicon cell line and its application for anti-SARS drug screening

The severe acute respiratory syndrome (SARS) outbreak in 2002, which had a high morbidity rate and caused worldwide alarm, remains untreated today even though SARS was eventually isolated and controlled. Development and high-throughput screening of efficacious drugs is therefore critical. However, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Feng, Luo, Yonghu, Liew, Pei Xiong, Hung, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103326/
https://www.ncbi.nlm.nih.gov/pubmed/17098272
http://dx.doi.org/10.1016/j.virol.2006.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103326/
https://www.ncbi.nlm.nih.gov/pubmed/17098272
http://dx.doi.org/10.1016/j.virol.2006.10.016

Ejemplares similares